Dean Kereiakes, M.D., medical director of The Christ Hospital Heart and Vascular Center, and a lead investigator for ...
October 23, 2015 โ Results of the TUXEDO trial, designed to compare two types of stents in diabetic patients, found ...
October 16, 2015 โ Results from a clinical trial showed that Abbott's Absorb everolimus-eluting bioresorbable vascular ...
October 15, 2015 โ Two new advances in stent technology announced in recent days further reinforce the effectiveness of ...
September 4, 2015 โ A drug-eluting coronary stent made of absorbable material performed similarly to gold-standard metal ...
September 1, 2015 โ A bioresorbable drug-eluting coronary stent showed similar efficacy and safety results compared to a ...
September 1, 2015 โ Extending treatment with the anticoagulant bivalirudin for at least four hours after completion of ...
August 17, 2015 โ The global interventional cardiology devices market is expected to reach $25.16 billion by 2020 ...
August 5, 2015 โ The global market value for bioabsorbable scaffolds (BAS) will expand rapidly from $143.7 million in ...
August 5, 2015 โ Abbott announced Monday that it has entered into an agreement to purchase Tendyne Holdings Inc., a ...